Dr. Jesmarie Correa-Lasanta, MD

Dr. Correa-Lasanta practices at Holmes Regional Medical Center in Melbourne, Florida, part of Health First.

Dr. Correa-Lasanta's NPI, 1285043901, was assigned on August 6, 2014. Dr. Correa-Lasanta holds Florida license ME131933.

Dr. Correa-Lasanta's primary practice is Holmes Regional Medical Center, at 1350 S Hickory St, Melbourne, FL 32901 in Brevard County. The practice phone is (321) 434-7000.

Dr. Correa-Lasanta's primary practice is Holmes Regional Medical Center in Melbourne, Florida, part of Health First. Dr. Correa-Lasanta is also affiliated with Viera Hospital. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Correa-Lasanta to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Correa-Lasanta practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Correa-Lasanta's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Correa-Lasanta is licensed in Florida.

CMS data shows 839 Medicare services from Dr. Correa-Lasanta across 3 procedure codes in 2024, for 288 Medicare patients. Medicare paid $68,847 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 288 Medicare patients who saw Dr. Correa-Lasanta in 2024. The largest group is 75 to 84, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Correa-Lasanta's median patient age at 70, with 49% women.

In 2024, Dr. Correa-Lasanta wrote 120 Medicare Part D claims for 32 patients. 93% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $55,133 in total drug cost. In 2023, CMS named 89 claims across 5 drugs.

Dr. Correa-Lasanta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 55 general payments to Dr. Correa-Lasanta from 15 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 92% of the total. Gilead Sciences, Inc. paid the most, $399.